Valuation (47%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -150.10 | 20.39 |
PEG Ratio (TTM) | 6.13 | 15.94 |
P/S Ratio (TTM) | 2.53 | 7.09 |
P/B Ratio (TTM) | 2.13 | 5.96 |
P/FCF Ratio (TTM) | 29.65 | 16.85 |
Price to 5YR AVG Earnings Ratio | 55.86 | 109.59 |
Price to 5YR AVG FCF Ratio | 52.51 | 38.41 |
Profitability (5%) |
Company | Industry |
---|---|---|
ROA (TTM) | -0.69% | 1.28% |
ROE (TTM) | -1.43% | 8.68% |
Net Profit Margin (TTM) | -1.68% | 4.95% |
ROIC 5YR AVG | 4.42% | 11.87% |
Growth (77%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -550.64% | 289.43% | 164.95% |
Revenue | 2.89% | 19.92% | 21.41% |
Net Income | -546.94% | 320.76% | 180.40% |
Cash Flow | 4.29% | 94.25% | 742.87% |
Health (46%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.84 | 2.49 |
Quick Ratio (TTM) | 1.84 | 2.31 |
D/E Ratio (TTM) | 0.81 | 0.72 |
Interest Coverage (TTM) | 1.09 | 6.58 |
Piotroski F-Score | 8 | 5 |
Altman Z-Score | 1.73 | 7.57 |
LTL to 5YR AVG FCF | 14.39 | 2.13 |
Shares Outstanding Growth 5YR AVG | 37.61% | 4.82% |